New Lilly Diabetes Center of Excellence Established at the Indiana Bioscience Research Institute

INDIANAPOLIS, Sept. 13, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and the Indiana Bioscience Research Institute (IBRI), in collaboration with Indiana University School of Medicine,......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Thursday, 13 September

Share |